Sage Therapeutics Inc. sell Bank of America Co.
Start price
09.10.24
/
50%
€5.99
Target price
09.10.25
€5.48
Performance (%)
26.80%
End price
10.10.25
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 26.80%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Bank of America Co. from $11.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.76
11.03.25
11.03.25
€4.61
11.03.26
11.03.26
12.51%
12.03.26
12.03.26
